General Mills (NYSE:GIS), Inc. GIS is scheduled to report fourth-quarter fiscal 2020 results on Jul 1. This global manufacturer and marketer of branded consumer foods has a trailing four-quarter positive earnings surprise of 5.6%, on average.
The Zacks Consensus Estimate for fourth-quarter earnings has gone down by a penny to $1.04 per share in the past 30 days. This suggests a rise of 25.3% from the figure reported in the year-ago quarter. The consensus mark for revenues is pegged at $4.88 billion, which indicates growth of 17.3% from the year-ago quarter’s reported figure.
The Zacks Consensus Estimate for fiscal 2020 earnings is pegged at $3.54 per share, which suggests growth of 9.9% from the figure reported in the year-ago period. For fiscal 2020, the consensus mark for revenues is pegged at $17.53 billion.
General Mills, Inc. Price and EPS Surprise
General Mills, Inc. price-eps-surprise | General Mills, Inc. Quote
Factors at Play
In a recent press release, General Mills notified that it has been witnessing higher consumer demand for its products in at-home food segment. The upside can be attributed to panic-induced stockpiling amid the coronavirus outbreak. For the fiscal fourth quarter, management expects organic sales growth of double digits year over year. Further, the company anticipates adjusted operating profit at constant currency (cc) to have increased at a faster rate than organic net sales in the to-be-reported quarter.
Additionally, General Mills anticipates to have exceeded it’s previously provided fiscal 2020 guidance in the quarter under review. For fiscal 2020, General Mills had earlier anticipated 1-2% improvement in organic sales and 4-6% growth in adjusted operating profit (at cc). Moreover, the company had envisioned a 6-8% rise in adjusted earnings per share (at cc).
However, the company informed that it expects a greater impact of unfavorable currency translations as well as divestitures in the fiscal fourth quarter. Moreover, the company’s away-from-home food business has been witnessing challenges amid the pandemic.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for General Mills this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
General Mills carries a Zacks Rank #3 and an Earnings ESP of +2.10%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other Stocks With Favorable Combination
Here are some other companies that you may want to consider as our model shows that these also have the right combination of elements to post an earnings beat.
Helen of Troy HELE has an Earnings ESP of +11.48% and a Zacks Rank #1.
Kimberly-Clark (NYSE:KMB) KMB has an Earnings ESP of +1.78% and a Zacks Rank #2.
Conagra Brands (NYSE:CAG) Inc. CAG has an Earnings ESP of +2.24% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
KimberlyClark Corporation (KMB): Free Stock Analysis Report
Conagra Brands Inc. (CAG): Free Stock Analysis Report
General Mills, Inc. (GIS): Free Stock Analysis Report
Helen of Troy Limited (HELE): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research